One major spine devicemaker merger is in the books for 2023, and another is on the horizon.
Here are six CEOs to know in the spine device industry:
Vafa Jamali, CEO of ZimVie: Mr. Jamali has more than 25 years of experience working with devicemakers including Medtronic, Covidien, Cardinal Health and Baxter. At Medtronic, he helped lead a team of 10,000 across four businesses. He was appointed as Zimmer Biomet's spine and dental spinoff in February, 2021.
Kevin Lobo, CEO of Stryker: Mr. Lobo was named CEO in 2012 and became board chair about two years later. He joined Stryker in 2011 and was previously group president of orthopedics. Mr. Lobo also has experience working with KPMG, Unilever, Kraft Canada, Rhone-Poulenc and Johnson and Johnson.
Geoffrey Martha, CEO of Medtronic: Mr. Martha became CEO of Medtronic in 2020 amid the COVID-19 pandemic. He oversees 95,000 employees across the $32 billion company. During his tenure, Medtronic has been recognized for its work with inclusion, diversity and equity.
Patrick Miles, CEO of Alphatec: Mr. Miles has been chair and CEO since 2017, and he previously worked at NuVasive. He had additional experience at devicemakers including Smith+Nephew, Medtronic and ORATEC Interventions.
Dan Scavilla, president and CEO of Globus Medical: Mr. Scavilla stepped in as CEO in April 2022, and is expected to lead Globus Medical and NuVasive's merged company. He began working at Globus Medical as CFO in 2015. Previously, Mr. Scavilla worked at Johnson and Johnson.
Keith Valentine, CEO of Orthofix and SeaSpine's combined company: Mr. Valentine was named CEO when Orthofix and SeaSpine's merger closed in January. He was previously president and CEO of SeaSpine. He previously worked at NuVasive as president and COO, and he is a board member for SI-Bone, according to his LinkedIn profile.